¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"population problem"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natural population
    ÀÚ¿¬Áý´Ü
  • population
    1. Àα¸ 2. ¸ðÁý´Ü, Áý´Ü
  • population attributable risk
    ¸ðÁý´Ü±âÀÎÀ§Çèµµ
  • population density
    Àα¸¹Ðµµ
  • population dynamics
    Àα¸µ¿ÅÂ
  • population equivalent
    Àα¸ÇØ´ç·®
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ
  • population mean
    ¸ðÁý´ÜÆò±Õ
  • population medicine
    Àα¸ÀÇÇÐ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • model population
    ¸ðÇüÀα¸
  • national population mortality
    ±¹¹Î»ç¸Á·ü
  • population mean
    ¸ðÆò±Õ
  • population medicine
    Àα¸ÀÇÇÐ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ
  • natural population
    ÀÚ¿¬Áý´Ü, ÀÚ¿¬°³Ã¼±º
  • population
    Àα¸, ¸ðÁý´Ü
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
  • population variance
    ¸ðÁý´ÜºÐ»ê
  • population attributable risk
    ÀϹÝÀα¸±â¿©À§Çèµµ
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • population mortality table
    ±¹¹Î»ç¸Á·üÇ¥
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population growth
    Àα¸¼ºÀå(ËöË´ËÛËö).
  • population increase
    Àα¸Áõ°¡(ÊÙ̡˧).
  • population mean
    ¸ðÆò±Õ(ËḬ̂˻).
  • population mortality table
    ±¹¹Î»ý¸íÇ¥(Ë´ËÑË×ËḬ̂), ±¹¹Î»ç¸Á·üÇ¥(Ë´ËÑË×ËÎ Ëô̰).
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • population policy
    Àα¸Á¤Ã¥(ÊÙËøÌ¤).
  • population pyramid
    Àα¸¸ðÇü(ËöË´ËÎÌ´).
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼(ÊÙ̧ËÛ).
  • population variance
    ¸ðºÐ»ê(ËÎËÓË×).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • composition of population
    Àα¸±¸¼º(ËöË´ Ë´ËÛ).
  • infinite population
    ¹«ÇѸðÁý´Ü.
  • midyear population
    ¿¬¾ÓÀα¸(ËçËâËöË´).
  • model population
    ¸ðÇüÀα¸(ËÎÌ´ËöË´).
  • movement of population
    Àα¸À̵¿(ËöË´ ËöËÄ).
  • national population mortality
    ±¹¹Î»ç¸Á·ü(~Ë×ËÎËô).
  • natural population
    ÀÚ¿¬Áý´Ü(~̤ËÀ), ÀÚ¿¬°³Ã¼±º(~˧̧˴).
  • population
    Àα¸, ¸ðÁý´Ü(ËÎ̤ËÀ) Åë°èÀÇ , Áý´Ü, °³Ã¼±º(˧̧˴).
  • population density
    Àα¸¹Ðµµ(ÊÙËÑ̬).
  • population dynamics
    Áý´Üµ¿ÅÂ, Àα¸µ¿·ÂÇÐ(ÊÙËÄËç̰).
  • population equivalent
    Àα¸´ç·®(ÊÙËÀËâ).
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ(ÊÙËôËøÌ°).
  • population growth
    Àα¸¼ºÀå(ËöË´ËÛËö).
  • population increase
    Àα¸Áõ°¡(ÊÙ̡˧).
  • population mean
    ¸ðÆò±Õ(ËḬ̂˻).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HARP homeless and at-risk population
MPD main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe...
PDL pancreatic duct ligation; periodontal ligament; poorly differentiated lymphocyte; population doublin...
PDT photodynamic therapy; population doubling time
Pop popliteal; population
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NPHS National Population Health Survey
POHEM POpulation HEalth Model
PAR Population Attributable Risk
PD Population doublings
pEPSP population excitatory postsynaptic potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • systemic related problem
    Àü½ÅÀû ¹®Á¦
  • whole problem
    Àüü ¹®Á¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
population density <epidemiology> Number of individuals in a population relative to space.
(12 Dec 1998)
population diffusion coefficient <cell biology> Coefficient that describes the tendency of a population of motile cells to diffuse through the environment. Its use presupposes that the cells move in a random walk.
(18 Nov 1997)
population dynamics <epidemiology> The pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population.
(12 Dec 1998)
population genetics <epidemiology, genetics> The study of genetic influences on the components of cause and effect in the somatic characteristics of populations.
(05 Mar 2000)
population growth <epidemiology> Increase, over a specific period of time, in the number of individuals living in a country or region.
(12 Dec 1998)
population pyramid <epidemiology> Graphical representation of the age and sex composition of a population, constructed by computing the percentage distribution of the population in each age and sex class.
(05 Mar 2000)
population surveillance <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
(12 Dec 1998)
suburban population The inhabitants of peripheral or adjacent areas of a city or town.
(12 Dec 1998)
synchronous cell population <cell culture> A culture of cells that all divide in synchrony.
Particularly useful for certain studies of the cell cycle, cells can be made synchronous by depriving them of essential molecules, which are then restored. Synchronisation breaks down after a few cycles, however, as individual cells have unique division rates.
(19 Jan 1998)
q in population genetics The frequency of the less common of two different alternative (allelic) versions of a gene. (the frequency of the more common allele is p).
(12 Dec 1998)
topotypical population <zoology> Population occurring at the type locality from which the type specimen was taken.
(09 Jan 1998)
urban population The inhabitants of a city or town, including metropolitan areas and suburban areas.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á